Conmed Corp
NYSE:CNMD
Intrinsic Value
CONMED Corp. operates as a medical technology company, which engages in the development, manufacture and sale of surgical devices and related equipment. [ Read More ]
The intrinsic value of one CNMD stock under the Base Case scenario is 148.79 USD. Compared to the current market price of 71.08 USD, Conmed Corp is Undervalued by 52%.
Valuation Backtest
Conmed Corp
Run backtest to discover the historical profit from buying and selling CNMD stocks based on their intrinsic value.
Analyze the historical link between intrinsic value and market price to make more informed investment decisions.
Fundamental Analysis
Balance Sheet Decomposition
Conmed Corp
Current Assets | 615.6m |
Cash & Short-Term Investments | 24.3m |
Receivables | 242.3m |
Other Current Assets | 349.1m |
Non-Current Assets | 1.7B |
PP&E | 120.7m |
Intangibles | 1.5B |
Other Non-Current Assets | 107.3m |
Current Liabilities | 310.7m |
Accounts Payable | 88.2m |
Accrued Liabilities | 70.1m |
Other Current Liabilities | 152.4m |
Non-Current Liabilities | 1.2B |
Long-Term Debt | 973.1m |
Other Non-Current Liabilities | 181.9m |
Earnings Waterfall
Conmed Corp
Revenue
|
1.2B
USD
|
Cost of Revenue
|
-568.5m
USD
|
Gross Profit
|
676.2m
USD
|
Operating Expenses
|
-554.8m
USD
|
Operating Income
|
121.4m
USD
|
Other Expenses
|
-56.9m
USD
|
Net Income
|
64.5m
USD
|
Free Cash Flow Analysis
Conmed Corp
What is Free Cash Flow?
CNMD Profitability Score
Profitability Due Diligence
Conmed Corp's profitability score is 51/100. The higher the profitability score, the more profitable the company is.
Score
Conmed Corp's profitability score is 51/100. The higher the profitability score, the more profitable the company is.
CNMD Solvency Score
Solvency Due Diligence
Conmed Corp's solvency score is 38/100. The higher the solvency score, the more solvent the company is.
Score
Conmed Corp's solvency score is 38/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
CNMD Price Targets Summary
Conmed Corp
According to Wall Street analysts, the average 1-year price target for CNMD is 112.78 USD with a low forecast of 98.98 USD and a high forecast of 138.6 USD.
Ownership
CNMD Insider Trading
Buy and sell transactions by insiders
Period | Sold | Bought | Net |
---|---|---|---|
3 Months |
|
|
|
6 Months |
|
|
|
9 Months |
|
|
|
12 Months |
|
|
|
Shareholder Return
CNMD Price
Conmed Corp
Average Annual Return | 9.09% |
Standard Deviation of Annual Returns | 35.78% |
Max Drawdown | -66% |
Market Capitalization | 2.2B USD |
Shares Outstanding | 30 791 200 |
Percentage of Shares Shorted | 18.32% |
Company Profile
Country
Industry
Market Cap
Dividend Yield
Description
CONMED Corp. operates as a medical technology company, which engages in the development, manufacture and sale of surgical devices and related equipment. The company is headquartered in Largo, Florida and currently employs 3,800 full-time employees. The firm's products consist of orthopedic surgery and general surgery. Orthopedic surgery consists of sports medicine instrumentation and small bone, large bone, and specialty powered surgical instruments as well as imaging systems for use in minimally invasive surgery procedures including dissociated two horizontal deviation and three horizontal deviation vision technologies. General surgery consists of endo-mechanical instrumentation for minimally invasive laparoscopic and gastrointestinal procedures, a line of cardiac monitoring products as well as electrosurgical generators and related instruments. Its products are used by surgeons and physicians in a variety of specialties, including orthopedics, general surgery, gynecology, neurosurgery, thoracic surgery, and gastroenterology.
Contact
IPO
Employees
Officers
The intrinsic value of one CNMD stock under the Base Case scenario is 148.79 USD.
Compared to the current market price of 71.08 USD, Conmed Corp is Undervalued by 52%.